107 related articles for article (PubMed ID: 6552202)
41. Circulating immune complexes and complement in the course of multiple sclerosis.
Jans H; Heltberg A; Raun NE
Acta Neurol Scand; 1982 Oct; 66(4):488-96. PubMed ID: 6216715
[TBL] [Abstract][Full Text] [Related]
42. [Calcium and magnesium deficiency and C3 fraction of complement].
Chevalier P; Cornu A; Delpeuch F; Joseph A
C R Seances Acad Sci D; 1979 Jan; 288(2):267-70. PubMed ID: 111851
[TBL] [Abstract][Full Text] [Related]
43. [Circulating immune complexes and complement breakdown products in childhood IgA nephropathy].
Tanaka C; Suhara Y; Kikkawa Y
Nihon Jinzo Gakkai Shi; 1991 Aug; 33(8):709-17. PubMed ID: 1770631
[TBL] [Abstract][Full Text] [Related]
44. Relationship between anti-DNA antibodies complement consumption and circulating immune complexes in systemic lupus erythematosus.
Davis P; Cumming RH; Verrier-Jones J
Clin Exp Immunol; 1977 May; 28(2):226-32. PubMed ID: 301447
[TBL] [Abstract][Full Text] [Related]
45. [Complement C3 and C4 levels in serum from acute viral hepatitis].
Ozer FT; Barut A; Inal A; Hacibektaşoğlu A
Mikrobiyol Bul; 1992 Oct; 26(4):314-9. PubMed ID: 1435361
[TBL] [Abstract][Full Text] [Related]
46. Activation of the classical complement pathway in spontaneous bacterial peritonitis.
Bird G; Senaldi G; Panos M; Rolando N; Alexander G; Vergani D; Williams R
Gut; 1992 Mar; 33(3):307-11. PubMed ID: 1568647
[TBL] [Abstract][Full Text] [Related]
47. Development and application of an enzyme-linked immunosorbent assay for the quantitation of alternative complement pathway activation in human serum.
Mayes JT; Schreiber RD; Cooper NR
J Clin Invest; 1984 Jan; 73(1):160-70. PubMed ID: 6418767
[TBL] [Abstract][Full Text] [Related]
48. Serial analysis of circulating immune complexes, complement, and antithymocyte globulin antibodies in heart transplant recipients.
Harkiss GD; Brown DL; Cory-Pearce R; English TA
J Clin Immunol; 1983 Apr; 3(2):117-26. PubMed ID: 6343417
[TBL] [Abstract][Full Text] [Related]
49. Human serum induced opsonization of immunoglobulin G-coated polystyrene microspheres with complement components C3 and C4 as measured by flow cytometry.
Spycher MO; Spycher-Burger M; Späth PJ; Burckhardt JJ
J Immunol Methods; 1991 Dec; 145(1-2):83-92. PubMed ID: 1765669
[TBL] [Abstract][Full Text] [Related]
50. A comparative study of complement components in polyethylene glycol precipitated immune complexes from patients with ovarian cancer and patients with rheumatoid arthritis.
Mooney NA; Hay FC; Poulton TA
Clin Exp Immunol; 1983 Jun; 52(3):561-8. PubMed ID: 6603297
[TBL] [Abstract][Full Text] [Related]
51. In vitro effects of organic solvents on immunity indicators in serum.
Stefanovic J; Starsia Z; Murgasová I; Absolonová O
J Hyg Epidemiol Microbiol Immunol; 1987; 31(1):1-7. PubMed ID: 3571967
[TBL] [Abstract][Full Text] [Related]
52. Complement and sepsis.
Gutiérrez-Fernández J; Maroto MC; Piédrola G; Zamora E
Allergol Immunopathol (Madr); 1987; 15(3):145-9. PubMed ID: 3661354
[TBL] [Abstract][Full Text] [Related]
53. Complement components and activation in primary biliary cirrhosis.
Lindgren S; Laurell AB; Eriksson S
Hepatology; 1984; 4(1):9-14. PubMed ID: 6420306
[TBL] [Abstract][Full Text] [Related]
54. Determination of complement activating circulating immune complexes and an example for antigen specific immune complex assays.
Krapf F; Fuchs C; Herrmann M; Hoferichter S; Kalden JR
J Clin Lab Immunol; 1986 Dec; 21(4):183-7. PubMed ID: 3550093
[TBL] [Abstract][Full Text] [Related]
55. Complement components in kidney allograft recipients: relationship to cytomegalovirus infection.
Chatterjee S; Fiala M; Arroyave C; Azen S; Cosgrove D
J Med Virol; 1982; 9(3):237-44. PubMed ID: 6284872
[TBL] [Abstract][Full Text] [Related]
56. Significance of complement components C1q and C4 bound to circulating immune complexes in juvenile idiopathic arthritis: support for classical complement pathway activation.
Gilliam BE; Reed MR; Chauhan AK; Dehlendorf AB; Moore TL
Clin Exp Rheumatol; 2011; 29(6):1049-56. PubMed ID: 22153664
[TBL] [Abstract][Full Text] [Related]
57. Classical and alternative complement pathway activation in paracoccidioidomycosis.
de Messias IT; Mohren D
J Investig Allergol Clin Immunol; 1994; 4(2):91-5. PubMed ID: 7921333
[TBL] [Abstract][Full Text] [Related]
58. [Complement. Evaluation of some complement fractions in patients affected by neoplasia undergoing chemotherapy (author's transl)].
Ignesti C; Lenzi L; Salvadori D; Innocenti V; Baroncelli C; Casadei BM
Quad Sclavo Diagn; 1981 Jun; 17(2):152-6. PubMed ID: 6943601
[TBL] [Abstract][Full Text] [Related]
59. Fibronectin and circulating immune complexes in Behet's disease.
Ozoran K; Düzgün N; Tutkak H; Gürler A; Tokgöz G
Rheumatol Int; 1996; 15(6):221-4. PubMed ID: 8778949
[TBL] [Abstract][Full Text] [Related]
60. Immune complexes in schistosomiasis IV. C3, C4 and C1q characterization and correlation between C3 in serum and circulating IC levels.
Santoro F; Bout D; Camus D; Capron A
Rev Inst Med Trop Sao Paulo; 1977; 19(1):39-42. PubMed ID: 897474
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
